chrisvoncsefalvay/vaers-outcomes huggingface dataset:
May 20-22: full body joint & muscle aches, low-grade fever, pain at injection site, rotator cuff of the same shoulder was sore longer than the rest of my body. The worst day was the 21st. Ibuprofen (generic, 600mg) helped alleviate most symptoms.  May 23-25: nausea, vomiting, diarrhea, abdominal pain. Primarily abdominal pain (lower quadrants of abdomen) and diarrhea. No discoloration (no blood). Abdominal pain was moderate 23-24. Diarrhea stopped on the 25th. Abdominal pain still present, but mild, on the 26th.
07/30/04: Pt here for college immunizations, needs to restart DT and MMR series because has no records from home country. Pt received TD in left deltoid and then waited for 1-1.5 minutes between shots while chatting with the nurse within 15 seconds of receiving MMR in left arm pt stated "Whoa, I don't feel well." Eyes became glassy, sweat broke out and pt's head started swaying from side to side.  Pt was immediately laid down on exam table and feet elevated as nurse called for help. Pt's eyes rolled up and became unfocused, pt started grunting, all muscles became tonic with arms positioned bent at elbow's with fists at shoulders. Entire episode lasted 30 seconds. Pt's eyes refocused and pt states "I didn't know where I was". Felt like she was "soft and moving away and then I don't remember anything until I saw you ladies", but did not feel like when she had fainted in the past, 20 minutes later but states "feel tired and shaky". Pt stated she had only taken one Advil and one 100mg tablet of Doxycycline, denies any other drugs or alcohol today. No family history of seizures or nervous disorders.  07/30/04: Pt denies any history of reactions to immunizations in the past.  07/30/04: As above-called to assist nurse. Pt was having seizure-like activity. (unable to comprehend handwriting) a few seconds she started talking and re-orienting herself. US: 72-20; 118/70. A: Adverse reaction to MMR versus vasovagal episode. P: Call placed to consultant with state immunization branch. Stated that despite the listing of the MMR result made "Adverse reaction": afebrile convulsion as seizures, that it is unusual for an adult to have such an adverse reaction particularly so quickly after the injection was given. However, it did seem like an unusual vasovagal episode. She suggested that we witnessed the reaction (unable to comprehend handwriting) it to the CDC via the VAERS form. Pt re-evaluated color pink, skin dry, oriented x3 but still feeling a little anxious. Advised home for end drive her home. Called her employer at her request to inform that pt could not be at work today. Advised to go to ER if any recurrent symptoms. Advised consider MMR as allergy for future reference-do not get any further MMR shots. Left in stable condition with friend.
Pain in left arm where injection was given. Cannot lift arm associated with pain since date of injection. Patient sent for physical and occupational therapy. X-ray is normal. PT/OT without relief. Prescribed Celebrex and given orthopedic referral on 6/15/2016.
Symptoms began on 05/24/2022 with a bad runny nose and what I thought was a sinus infection. On 05/26/2022 I tested with a home test after loosing my sense of taste and smell. The test was positive. I contacted my doctor who prescribed PAXLOVID. I completed the five day course of the medication. It took about three weeks for me to get my sense of taste and smell back.
After aproximately 5 minutes of the shoots she felt nauseated and started to jerk her body around almost falling down, her eyes rolled back this lasted about 45 seconds. She was pale and sweating cold and felt dizzy. She was taken to a different room to lie down where her vital sign were checked. her blood pressure was higher than at the time of examination.She was given apple juice to raise her blood sugar level according to the nurse.
R sided Bells palsy developed early December. He did receive with fluzone in R deltoid 11/18/22. He has now been admitted to ICU with cellulitis of the L ear, face and neck with septic shock.
Pfizer 8/27/21, 3/15/22. Positive on 2/16/23 (offsite)
pt recvd vax; pt exp swollen glands; felt lump in throat & devel flu like symptoms; rxn attributed to flu vax;
several patients already exceeded the 6 month recommended schedule; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were received as follows: The age at vaccination was not applicable for this report. The reporter stated that the several patients already exceeded the 6 month recommended schedule from 2nd dose for Shingrix due to COVID 19. The reporter consented to follow up.
After receiving the vaccine about three weeks later, I started experiencing black outs and went to see a cardiac specialist and he did a ablation surgery and diagnosed CVT.
sick with covid; sick with covid; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Dec2021, outcome unknown. The patient was in clinical trial for the covid vaccine and was not yet eligible for the booster within the trial. It prevented patient from getting a booster and patient was now sick with covid. Reporter questioned will patient be helped for treatment.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Given Flumist. 15-20 min later c/o dizziness and tachycardia. Mom went to ER. Vital signs normal and was feeling better by time was seen.
Began experienced pinkness, warmness at injection site applied cold packs 10 min next morning began experiencing pain "4" 0-> 10 scale continued cold packs
Employee received first dose of Pfizer-BioNTech Covid-19 Vaccine on 12/28/20.  Per Employee's manager: Patient began experiencing symptoms of neuropathy and was admitted to the hospital as an inpatient on 1/18/21.  Informed from neurologist that most likely Guillain-Barré syndrome resulted from vaccine and instructed to not receive 2nd dose of vaccine at this time.
severe leg cramps; hard time walking; This is a spontaneous report from a contactable consumer (patient) reported for herself via Medical Information Team. A female patient of an unspecified age (70 unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 09Feb2021 (yesterday) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that today (10Feb2021) at around 9 AM started having severe leg cramps, had a hard time walking, was wondering if this could be related with the vaccine and was looking for information on taking ibuprofen for side effects of the vaccine. The outcome of the events was unknown.  Information about Batch/Lot number has been requested.  Follow-up attempts are completed. No further information is expected.
felt sick for 7 days; arm hurt for 7 days; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt sick for 7 days) and PAIN IN EXTREMITY (arm hurt for 7 days) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.    No Medical History information was reported.  On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (felt sick for 7 days) and PAIN IN EXTREMITY (arm hurt for 7 days). On 09-Mar-2021, MALAISE (felt sick for 7 days) and PAIN IN EXTREMITY (arm hurt for 7 days) had resolved.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-489037, MOD-2022-489192 (Patient Link).
Gave KINRIX on 7/22/09 in left upper arm.  On 7/24/09 came into office with redness on left upper arm.  Warm to touch.
Dry mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRY MOUTH (non-serious), outcome "unknown", described as "Dry mouth".  Additional Information: No underlying medical conditions.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on left wrist (red dots) in the morning.  In the afternoon it was all over left arm and right arm.  And this evening the rash is all over her back as well.  The rash is itchy and she is using Benadryl.  And she is also using oatmeal soap.
Vasovagal syncope approximately 5- 10 minutes post vaccination. Pt reports that he started to feel lightheaded and stood up and passed out. pt then hit his chin on a low setting wall and had a small 1cm laceration on his anterior chin. pt fell prior to my arrival to finding him down. when I arrived pt seemed to be mildly disoriented for about 30 seconds to 1 minute.  pt reports that he had + LOC for a few seconds while he fell but was conscious when I arrived.   pt was advised to seek out wound closure for chin laceration.
Right after he received his polio and d-tap shot, his leg started swelling and he was very tired. He fell asleep right after and slept for 5 hours, i had to wake him which is not normal. That night his leg started swelling even more and he spiked a fever up to 102 degrees. He was really lethargic and his leg continued to swell and become hard. The next day he was limping and his leg had swelled down to his knee and up to his hip. That night it also started to become even more hot and red, the redness started spreading up to his diaper area. That was on 10/05/19. On 10/06/2019, his leg is still swelling in size and becoming increasingly red. He will not let me touch it because it hurts him.
Caller states her eyes are not working right today; Started on Bexsero, got the 2nd dose as Trumenba; Started on Bexsero, got the 2nd dose as Trumenba; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 16-year-old female patient received meningococcal group b Rlp2086 (TRUMENBA), on 20Jul2022 as dose 2, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: bexsero (DOSE 1, Deltoid Right, lot number: ABXA87AZ), administration date: 22Jul2021, for immunisation. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 20Jul2022, outcome "unknown" and all described as "Started on Bexsero, got the 2nd dose as Trumenba"; OCULAR DISCOMFORT (non-serious) with onset 12Aug2022, outcome "unknown", described as "Caller states her eyes are not working right today". Additional information: dose is not interchangeable so the patient will need to go back for the 2nd dose of Bexsero. A patient that started on Bexsero at the office and then was referred to a pharmacy and got the 2nd dose as Trumenba and not the Bexsero for their 2nd dose.   Follow-up attempts are completed. No further information is expected.
caused Lymph nodes in neck and ear to swell up; This case was reported by a consumer via interactive digital media and described the occurrence of enlargement of lymph nodes in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced enlargement of lymph nodes. On an unknown date, the outcome of the enlargement of lymph nodes was unknown.   The reporter considered the enlargement of lymph nodes to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-May-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. The Shingles vaccine caused lymph nodes in patient's neck and behind the ear to swell up. The patient stated that he/she did not think he/she would get the second shot. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
A spontaneous report has been received from a Physician concerning a 6 year old, male subject, who had been receiving nasal FLUMIST Quadrivalent. The patient had received FLUMIST Quadrivalent started on 31-DEC-2014. The reporter stated that the patient inadvertently administered expired FLUMIST Quadrivalent to four patients which started on  21-DEC-2014. The outcome of the event of inadvertently administered expired FLUMIST Quadrivalent to four patients is unknown. The report was considered to be non-serious.
This case was reported by a consumer (also the subject) and described the occurrence of headache in a 56-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline), Tetanus vaccine (non-GSK). A physician or other health care professional has not verified this report. On 27 February 2012 the subject received 1st dose of TWINRIX (unknown route, unknown arm), and an unspecified dose of Tetanus vaccine (non-GSK) (details unknown). On 27 February 2012, less than one day after vaccination with Tetanus vaccine (non-GSK) and TWINRIX, the subject experienced headache and on 28 February 2012, one day after vaccination with Tetanus vaccine (non-GSK) and TWINRIX, the subject experienced fatigue. The subject wanted to take the second TWINRIX dose according to the accelerated dosing schedule.
Swelling from injection site to 2 inches above elbow, very itchy. Swelling/hot skin around entire upper arm.  By third day, swelling had migrated past elbow to upper forearm, still itchy.
Can't walk; Can't bend down; Very dizzy; Fever; the head hurts; feel pain in the right arm/whole body hurts/pain below her hips; Pain below her hips; Patient can't do anything; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Can't walk), HYPOKINESIA (Can't bend down), DIZZINESS (Very dizzy), PYREXIA (Fever) and HEADACHE (the head hurts) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 50AD27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included METOPROLOL, ATORVASTATIN, PROPAFENONE, VITAMIN B12 [VITAMIN B12 NOS], BORAGO OFFICINALIS OIL, FISH OIL, LINUM USITATISSIMUM OIL (TRIPLE OMEGA 3 6 9) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced GAIT INABILITY (Can't walk), HYPOKINESIA (Can't bend down), DIZZINESS (Very dizzy), PYREXIA (Fever), HEADACHE (the head hurts), MYALGIA (feel pain in the right arm/whole body hurts/pain below her hips), ARTHRALGIA (Pain below her hips) and FATIGUE (Patient can't do anything). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, GAIT INABILITY (Can't walk), HYPOKINESIA (Can't bend down), DIZZINESS (Very dizzy), PYREXIA (Fever), HEADACHE (the head hurts), MYALGIA (feel pain in the right arm/whole body hurts/pain below her hips), ARTHRALGIA (Pain below her hips) and FATIGUE (Patient can't do anything) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Additional information included updated outcome.
I am uncertain of the exact type of flu shot though the pharmacy would have that information. Pt woke with a headache, mild body aches. Later he stated that he had also had a tingly feeling in his body at one point in the morning but it went away. He felt mildly nauseated and his stomach hurt a little. Ibuprofin and activated charcoal helped off and on. He came home from school early. This morning he stayed home and has less of the headache but still feels a little 'sick'.
fever 100-102, coughing, SOB & tightening in chest;pt felt sick & feverish;devel hearing impairment;lt side chest pain, h/a, fatigue, diaphoresis, joint pain;dx viral infect;
Patient left the pharmacy after immunization, shopped in the store for a little while and then fell down during a checkout process at the front register. He told cashier that he tripped over something, but cashier thinks he looked a little dizzy before it happened. Patient refused the offer to call 911.
Still have the rash.. Still on different medications. Benedryl ,Pepcid,Hydroxyzine and Hydrocortisone cream.
3/23/21 ER HPI:49 y.o. female who presents with chest pain.  Patient reports she was laying in bed this morning around 4:00 a.m. when she started developing pain to left side of her chest.  Patient describes her pain as a sharp pressure that radiated to the left shoulder and jaw.  Patient reports pain currently 8/10 and worse was 9/10.  Patient reports associated shortness of breath, mild lightheadedness, and nausea.  Patient denies any vomiting or diaphoresis.  Patient has no known history of coronary artery disease and had a heart catheterization approximately 2 years ago that was negative.  Patient's cardiac risk factors include obesity, smoking, and family history.  Patient denies any history of DVT or PE
deep pain in left shoulder; not be able to go back to sleep; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3246), via intramuscular route of administration on 26Jan2021 at 19:30 as single dose in left deltoid, and second dose of BNT162B2 (Lot Number: EN6201), via unspecified route of administration, on 16Feb2021 18:30, as single dose in left deltoid for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 30Jan2021, the patient experienced deep pain in left shoulder. Pain was not muscular as much as seemingly in the shoulder socket. Not as noticeable when active in the day but makes it difficult to sleep well or will wake him up hurting and not be able to go back to sleep. Patient don't know if it was a nerve issue of the joint but does not feel like the muscle itself. Pain seems to be constant, but more pronounced on times. There was no treatment received for the events. Outcome of the event was not recovered for deep pain in left shoulder and unknown for sleep disorder.  No follow-up attempts are needed. No further information is expected.
pt recvd vax & approx 2-3 hrs later began loud pitch screaming cry; pt recvd APAP a/seeing MD; pt's fever was not taken;
Swollen tongue sensation (not visible by provider) and fuzzy feeling sensation; provider stated that exam was normal
Chest cold; Bad sinus and chest cold; Sore from head to toe; A spontaneous report was received from a reporter(consumer) concerning a 65-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chest cold/lower respiratory tract infection, bad sinus/sinusitis and sore from head to toe/pain.  The patient's medical history was not provided. No concomitant product use was reported.  On 18 Feb 2021, the patient received the first of two planned doses of mRNA-1273 (Lot number: not provided) in the left arm intramuscularly for prophylaxis of COVID-19 infection.   On 20 Feb 2021, the reporter stated the patient had severe side effects. The patient had a bad sinus and chest cold and felt sore from head to their toes.    No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events, chest cold/lower respiratory tract infection, bad sinus/sinusitis and sore from head to toe/pain, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This initial non-serious spontaneous case, received on 26-Oct-2017, reported by other non-health professional and concerns a female pregnant patient of unspecified age. On an unspecified date, the patient was administered with FLUCELVAX QIV (dose, route of administration, anatomical location, expiry date and batch number: not reported) (explicitly coded as vaccine exposure during pregnancy). On the same day after administration of vaccine, the patient stated that she started having gas and experienced indigestion. It was reported that, gas travelled through her back and stomach which caused a lot of pain. At the time of this report, the outcome of the events was not reported.
Nausea; headache; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A patient (no qualifiers provided) received meningococcal group b Rlp2086 (TRUMENBA), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown". Additional information included: Event took place after use of product. The information on the batch/lot number for meningococcal group b Rlp2086 has been requested and will be submitted if and when received.
My daughter complained that her "brain hurt" and started to cry. She then fainted when she stepped in to the car. She was unresponsive for a couple of seconds. She was weak, pale, and disoriented. The nurses took her to a separate room, tested her blood pressure (which they stated was low at first) and put a cool towel on her head.
Dizziness; This is a spontaneous report from a contactable physician.   A 16/17 year old adolescent patient of an unspecified gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration at single dose on an unspecified date for immunisation.  The patient medical history and concomitant medications were not reported. The patient experienced dizziness on an unspecified date with outcome of unknown. Physician specified the adolescent didn't eat anything in the AM/PM.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
Mom in today states child had seizures 5 days after shots; was airlifted to hospital - states cause of seizures undiagnosed at hospital. Did not report until today child had fever and teething after shots. Unable to contact mother for more information.
Patient c/o nausea,  vomiting, diarrhea and dyspnea for 2 days.  Resident of assisted living facility, presented to emergency department of local hospital where she was admitted for COVID pneumonia.